AxoGen (AXGN) News Today $18.27 -0.04 (-0.22%) Closing price 04:00 PM EasternExtended Trading$18.27 0.00 (-0.01%) As of 05:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period FY2024 EPS Estimates for AxoGen Lowered by Cantor FitzgeraldJanuary 25, 2025 | americanbankingnews.comCantor Fitzgerald Reduces Earnings Estimates for AxoGenAxoGen, Inc. (NASDAQ:AXGN - Free Report) - Investment analysts at Cantor Fitzgerald reduced their FY2024 EPS estimates for AxoGen in a research report issued to clients and investors on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn now anticipates that the medical equipment providerJanuary 23, 2025 | marketbeat.comAxoGen (NASDAQ:AXGN) Reaches New 1-Year High - Time to Buy?AxoGen (NASDAQ:AXGN) Sets New 52-Week High - Here's WhyJanuary 23, 2025 | marketbeat.comAxogen stock soars to 52-week high, touches $18.99January 21, 2025 | msn.comAxoGen, Inc. (NASDAQ:AXGN) Shares Sold by Assenagon Asset Management S.A.Assenagon Asset Management S.A. decreased its stake in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 37.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 826,536 shares of the medical equipment provider's stock after selling 48January 18, 2025 | marketbeat.comAxoGen (NASDAQ:AXGN) Sets New 52-Week High - Still a Buy?AxoGen (NASDAQ:AXGN) Hits New 1-Year High - Should You Buy?January 17, 2025 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Shares Bought by JPMorgan Chase & Co.JPMorgan Chase & Co. lifted its stake in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 2,912.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 549,000 shares of the medical equipment provider's stock after purchasingJanuary 15, 2025 | marketbeat.comBarclays PLC Raises Holdings in AxoGen, Inc. (NASDAQ:AXGN)Barclays PLC grew its stake in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 119.3% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 72,036 shares of the medical equipment provider's stock after buying an additional 39,182 shares during the quarter. Barclays PLC owJanuary 15, 2025 | marketbeat.comAxoGen (NASDAQ:AXGN) Hits New 1-Year High - Still a Buy?AxoGen (NASDAQ:AXGN) Reaches New 12-Month High - Here's What HappenedJanuary 11, 2025 | marketbeat.comAxogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)January 10, 2025 | globenewswire.comAxoGen (NASDAQ:AXGN) Trading Up 6.7% - Still a Buy?AxoGen (NASDAQ:AXGN) Trading 6.7% Higher - Should You Buy?January 10, 2025 | marketbeat.comAxogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024January 10, 2025 | markets.businessinsider.comAxogen: Well Placed To Capitalize Growth At Higher MultiplesJanuary 6, 2025 | seekingalpha.comAxoGen (NASDAQ:AXGN) Stock Price Down 4.8% - What's Next?AxoGen (NASDAQ:AXGN) Shares Down 4.8% - Should You Sell?January 3, 2025 | marketbeat.comShort Interest in AxoGen, Inc. (NASDAQ:AXGN) Decreases By 7.3%AxoGen, Inc. (NASDAQ:AXGN - Get Free Report) was the target of a large decrease in short interest during the month of December. As of December 15th, there was short interest totalling 1,010,000 shares, a decrease of 7.3% from the November 30th total of 1,090,000 shares. Based on an average trading volume of 356,700 shares, the short-interest ratio is currently 2.8 days.December 31, 2024 | marketbeat.comGeode Capital Management LLC Buys 31,612 Shares of AxoGen, Inc. (NASDAQ:AXGN)Geode Capital Management LLC lifted its stake in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 3.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,010,508 shares of the medical equipment provider'December 31, 2024 | marketbeat.comBarclays PLC Purchases 39,182 Shares of AxoGen, Inc. (NASDAQ:AXGN)Barclays PLC lifted its position in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 119.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 72,036 shares of the medical equipment provider's stockDecember 31, 2024 | marketbeat.comState Street Corp Purchases 95,051 Shares of AxoGen, Inc. (NASDAQ:AXGN)State Street Corp raised its holdings in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 11.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 896,674 shares of the medical equipment provider's stock afterDecember 26, 2024 | marketbeat.comAxoGen (NASDAQ:AXGN) Stock Price Down 4.8% - Should You Sell?AxoGen (NASDAQ:AXGN) Shares Down 4.8% - Here's WhyDecember 24, 2024 | marketbeat.comAxoGen (NASDAQ:AXGN) Hits New 52-Week High - Still a Buy?AxoGen (NASDAQ:AXGN) Reaches New 12-Month High - Time to Buy?December 23, 2024 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Shares Sold by M&T Bank CorpM&T Bank Corp cut its holdings in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 50.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 34,682 shares of the medical equipment provider's stock after selling 35,826 shaDecember 18, 2024 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Shares Acquired by Fmr LLCFmr LLC raised its holdings in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 743.1% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 178,957 shares of the medical equipment provider's stDecember 15, 2024 | marketbeat.comThose who invested in Axogen (NASDAQ:AXGN) a year ago are up 98%December 6, 2024 | uk.finance.yahoo.comParkman Healthcare Partners LLC Buys New Shares in AxoGen, Inc. (NASDAQ:AXGN)Parkman Healthcare Partners LLC acquired a new stake in AxoGen, Inc. (NASDAQ:AXGN - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 412,888 shares of the medical equipment provider's stock, valued at approDecember 4, 2024 | marketbeat.comLeerink Partners Reaffirms Their Buy Rating on AxoGen (AXGN)November 28, 2024 | markets.businessinsider.comLeerink Partnrs Issues Positive Forecast for AxoGen EarningsAxoGen, Inc. (NASDAQ:AXGN - Free Report) - Investment analysts at Leerink Partnrs raised their FY2024 earnings per share (EPS) estimates for shares of AxoGen in a research note issued to investors on Monday, November 25th. Leerink Partnrs analyst M. Kratky now expects that the medical equipment pNovember 27, 2024 | marketbeat.comEagle Asset Management Inc. Makes New $1.73 Million Investment in AxoGen, Inc. (NASDAQ:AXGN)Eagle Asset Management Inc. acquired a new stake in AxoGen, Inc. (NASDAQ:AXGN - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 123,279 shares of the medical equipment provider's stock, valueNovember 26, 2024 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Purchases 123,118 Shares of AxoGen, Inc. (NASDAQ:AXGN)Connor Clark & Lunn Investment Management Ltd. raised its position in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 66.3% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 308,686 shares of the medicNovember 24, 2024 | marketbeat.comTop 10 most expensive stocks (only 1 gets a Quant Sell)November 17, 2024 | msn.comAxoGen, Inc. (NASDAQ:AXGN) Short Interest Down 8.1% in OctoberAxoGen, Inc. (NASDAQ:AXGN - Get Free Report) saw a large decline in short interest during the month of October. As of October 31st, there was short interest totalling 1,130,000 shares, a decline of 8.1% from the October 15th total of 1,230,000 shares. Based on an average trading volume of 430,300 shares, the short-interest ratio is presently 2.6 days.November 17, 2024 | marketbeat.comAxoGen’s Sales Surge and Strategic Leadership Inspire a Buy Rating Amidst Growth OpportunitiesNovember 12, 2024 | markets.businessinsider.comAxoGen’s Strong Q3 Performance and Strategic Advancements Underpin Buy RatingNovember 9, 2024 | markets.businessinsider.comAxogen, Inc (AXGN) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comAxoGen Reports Strong Q3 2024 Revenue GrowthNovember 8, 2024 | finance.yahoo.comAxoGen’s Strong Q3 Performance and Strategic Outlook Underpin Buy RatingNovember 8, 2024 | markets.businessinsider.comAxoGen reports Q3 adjusted EPS 7c, consensus 1cNovember 8, 2024 | markets.businessinsider.comAxogen Reports Strong Q3 Growth and FDA ProgressNovember 8, 2024 | markets.businessinsider.comAxogen Inc (AXGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic AdvancementsNovember 8, 2024 | finance.yahoo.comAxoGen (NASDAQ:AXGN) Trading Down 11.2% - Here's WhyAxoGen (NASDAQ:AXGN) Stock Price Down 11.2% - Here's WhyNovember 7, 2024 | marketbeat.comAxoGen (NASDAQ:AXGN) Hits New 12-Month High - Here's WhyAxoGen (NASDAQ:AXGN) Hits New 52-Week High - What's Next?November 5, 2024 | marketbeat.comAxoGen (AXGN) to Release Earnings on ThursdayAxoGen (NASDAQ:AXGN) will be releasing earnings before the market opens on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=639574)October 31, 2024 | marketbeat.comSemanteon Capital Management LP Acquires Shares of 43,016 AxoGen, Inc. (NASDAQ:AXGN)Semanteon Capital Management LP bought a new position in AxoGen, Inc. (NASDAQ:AXGN - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 43,016 shares of the medical equipment pOctober 29, 2024 | marketbeat.comLeerink Partnrs Brokers Cut Earnings Estimates for AxoGenAxoGen, Inc. (NASDAQ:AXGN - Free Report) - Equities research analysts at Leerink Partnrs reduced their FY2028 EPS estimates for AxoGen in a research note issued to investors on Tuesday, October 15th. Leerink Partnrs analyst M. Kratky now anticipates that the medical equipment provider will post eOctober 18, 2024 | marketbeat.comAxoGen (NASDAQ:AXGN) Shares Down 4.3% - What's Next?AxoGen (NASDAQ:AXGN) Shares Down 4.3% - What's Next?October 17, 2024 | marketbeat.comExchange Traded Concepts LLC Reduces Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN)Exchange Traded Concepts LLC lowered its holdings in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 49.3% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 74,742 shares of the medical equipment provider's stock after seOctober 17, 2024 | marketbeat.comAxoGen (NASDAQ:AXGN) Hits New 52-Week High - What's Next?AxoGen (NASDAQ:AXGN) Reaches New 1-Year High - Time to Buy?October 16, 2024 | marketbeat.comStockNews.com Upgrades AxoGen (NASDAQ:AXGN) to "Buy"StockNews.com upgraded AxoGen from a "hold" rating to a "buy" rating in a research note on Tuesday.October 15, 2024 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Shares Sold by Millennium Management LLCMillennium Management LLC trimmed its stake in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 48.2% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 681,755 shares of the medical equipment provideOctober 13, 2024 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Sees Large Drop in Short InterestAxoGen, Inc. (NASDAQ:AXGN - Get Free Report) saw a large decline in short interest in the month of September. As of September 30th, there was short interest totalling 1,210,000 shares, a decline of 25.8% from the September 15th total of 1,630,000 shares. Based on an average trading volume of 439,100 shares, the days-to-cover ratio is currently 2.8 days.October 12, 2024 | marketbeat.comAxoGen (NASDAQ:AXGN) Sees Strong Trading Volume - Here's What HappenedAxoGen (NASDAQ:AXGN) Sees Strong Trading Volume - What's Next?October 11, 2024 | marketbeat.com Get AxoGen News Delivered to You Automatically Sign up to receive the latest news and ratings for AXGN and its competitors with MarketBeat's FREE daily newsletter. Email Address AXGN Media Mentions By Week AXGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AXGN News Sentiment▼-0.160.74▲Average Medical News Sentiment AXGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AXGN Articles This Week▼53▲AXGN Articles Average Week Get AxoGen News Delivered to You Automatically Sign up to receive the latest news and ratings for AXGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NVCR News LIVN News ENOV News WRBY News TNDM News LMAT News CNMD News TMDX News SLNO News CDRE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AXGN) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredDonald Trump is about to free crypto from its chains …On October 25th, Juan said Bitcoin would cross $100,000 before the inauguration. Now he thinks it could rea...Weiss Ratings | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredTrillion-Dollar Crypto PlayPotential $20-trillion opportunity? Put $500 into THIS AI Coin for 2025… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AxoGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AxoGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
